Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▼Subject
 26.4.2019Viatris Limited (VIM)08255Vancomycin Mylan 500 mg (plv ifo 1x500 mg (liek.inj.skl.))30.4.2019O
 30.4.2019Pfizer Europe MA EEIG (PFI-BE-3)25313DIFLUCAN P.O.S. 10 mg/ml (plu por 1x24,4 g (fľ.HDPE+odm.lyžička alebo striekačka))30.4.2019O
 10.6.2021Immedica Pharma AB (IMD-SE)41078Ammonaps 940 mg/g granuly (gra 1x266 g (fľ.HDPE+3 odm.lyžice))30.4.2019Z
 30.4.2019Pfizer Europe MA EEIG (PFI-BE-3)03365DALACIN C 150 mg (cps dur 16x150 mg (blis.PVC/Al))30.4.2019O
 30.4.2019Pfizer Europe MA EEIG (PFI-BE-3)25314DIFLUCAN P.O.S. 40 mg/ml (plu por 1x24,4 g (fľ.HDPE+odm.lyžička alebo striekačka))30.4.2019O
 15.4.2019Egis Pharmaceuticals PLC (EGI)5063BExplemed Rapid 15 mg (tbl oro 56x15 mg (blis.OPA/Al/PVC/PET/Al))30.4.2019R
 30.4.2019Pfizer Europe MA EEIG (PFI-BE-3)23735FSME-IMMUN 0,25 ml Junior Injekčná suspenzia (sus inj 1x0,25 ml/1,19 µg (striek.inj.skl.+ihla))30.4.2019O
 30.4.2019Pfizer Europe MA EEIG (PFI-BE-3)05886GENOTROPIN 12 mg (plv iol 1x12 mg (náplň inj.skl.dvojkom.+pero GoQuick))30.4.2019O
 10.6.2021Immedica Pharma AB (IMD-SE)41079Ammonaps 940 mg/g granuly (gra 1x532 g (fľ.HDPE+3 odm.lyžice))30.4.2019Z
 16.4.2019Dr. Willmar Schwabe GmbH & Co. KG (SCE)75123Tebokan 40 mg (tbl flm 20x40 mg (blis.PVC/Al))1.5.2019Z
 30.4.2019Pfizer Europe MA EEIG (PFI-BE-3)09710SOLU-MEDROL 125 mg (plv iol 1x125 mg+2 ml solv. (1x dvojkomorová Act-O-Vial))3.5.2019O
 7.5.2019Teva Czech Industries s.r.o. (TEV-CZ-2)4799CPLEUMOLYSIN (gto por 1x10 ml (fľ.skl.hnedá s bezpeč.uzáver.))3.5.2019R
 2.5.2019Mylan Pharmaceuticals Limited (MLB-IE-1)5435BPregabalin Mylan 300 mg tvrdé kapsuly (cps dur 56x300 mg (blis.PVC/PVDC/Al))3.5.2019O
 26.6.2019Accord Healthcare S.L.U (ACC-ES)6056BTemozolomide Accord 20 mg tvrdé kapsuly (cps dur 5x20 mg (vre.PET/Al/PE))3.5.2019R
 3.5.2019GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)26253Fenistil 1 mg/g gél (gel der 1x30 g (tuba Al))3.5.2019O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)